The Europe medical cannabis market hit $2.17 billion in 2023, and it's projected to soar to $11.09 billion by 2032, growing at a CAGR of 19.3% from 2024-2032. This growth is driven by increasing legalization, expanding therapeutic uses, and rising patient demand. Advancements in cultivation, extraction technologies, strategic partnerships, and growing R&D investments are also fueling ... https://www.imarcgroup.com/europe-medical-cannabis-market